Grufity logo
Grufity logo

Latest ARMISTICE CAPITAL, LLC Stock Portfolio

$8.17Billion | No. of Holdings #323

ARMISTICE CAPITAL, LLC Performance

2026 Q2+15.01%
YTD+6.57%
2025+10.43%

About ARMISTICE CAPITAL, LLC and 13F Hedge Fund Stock Holdings

ARMISTICE CAPITAL, LLC is a hedge fund based in New York, NY. On 2026-08-14, the fund reported it's updated stock portfolio. In the 13F Holdings report, ARMISTICE CAPITAL, LLC reported an equity portfolio of $8.2 Billions as of 30 Jun, 2026. <br><br> The top stock holdings of ARMISTICE CAPITAL, LLC are MDGL, SUPN, CYTK. The fund has invested 1.9% of it's portfolio in MADRIGAL PHARMACEUTICALS INC and 1.5% of portfolio in SUPERNUS PHARMACEUTICALS. <br><br> The fund managers got completely rid off AVANOS MED INC (AVNS), MEDLINE INC and KALVISTA PHARMACEUTICALS INC (KALV) stocks. They significantly reduced their stock positions in ERNEXA THERAPEUTICS INC, DATADOG INC (DDOG) and LOWES COS INC (LOW). ARMISTICE CAPITAL, LLC opened new stock positions in WATERS CORP (WAT), ILLUMINA INC (ILMN) and PRESTIGE CONSMR HEALTHCARE I (PBH). The fund showed a lot of confidence in some stocks as they added substantially to ZETA GLOBAL HOLDINGS CORP (ZETA), STITCH FIX INC (SFIX) and HONEST CO INC (HNST).
ARMISTICE CAPITAL, LLC Equity Portfolio Value
Last Reported on: 14 Aug, 2026
$8.17Billion
  as of Aug 14, 2026

ARMISTICE CAPITAL, LLC Annual Return Estimates Vs S&P 500

Our best estimate is that ARMISTICE CAPITAL, LLC made a return of 15.01% in the last quarter. In trailing 12 months, it's portfolio return was 31.31%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
waters corp28,129,500
illumina inc16,021,300
prestige consmr healthcare i15,882,700
liberty media corp del15,708,200
integer hldgs corp15,675,900
live nation entertainment in14,982,800
novo-nordisk a s14,957,300
twist bioscience corp14,609,000
New stocks bought by ARMISTICE CAPITAL, LLC

Additions

Ticker% Inc.
zeta global holdings corp8,677
stitch fix inc840
honest co inc728
dutch bros inc488
first watch restaurant group427
airbnb inc391
intellia therapeutics inc346
sanofi sa254
Additions to existing portfolio by ARMISTICE CAPITAL, LLC

Reductions

Ticker% Reduced
ernexa therapeutics inc-96.00
datadog inc-81.93
lowes cos inc-80.8
ulta beauty inc-72.63
sandisk corp-72.31
western digital corp-71.92
credit accep corp mich-68.99
travere therapeutics inc-67.89
ARMISTICE CAPITAL, LLC reduced stake in above stock

Sold off

Ticker$ Sold
sangamo therapeutics inc-9,974,780
outlook therapeutics inc-857,774
inspira technologies oxy bhn-1,848,520
esperion therapeutics inc ne-10,768,500
lineage cell therapeutics in-5,028,820
icecure medical ltd caesarea-816,312
avanos med inc-28,020,000
bioxcel therapeutics inc-2,559,500
ARMISTICE CAPITAL, LLC got rid off the above stocks

Sector Distribution

ARMISTICE CAPITAL, LLC has about 59.4% of it's holdings in Healthcare sector.

  • Healthcare
  • Technology
  • Others
  • Consumer Cyclical
  • Consumer Defensive
  • Communication Services
  • Industrials
Sector%
Healthcare59.4
Technology13.4
Others12.5
Consumer Cyclical7.2
Consumer Defensive3.2
Communication Services2.6
Industrials1.1

Market Cap. Distribution

ARMISTICE CAPITAL, LLC has about 36.7% of it's portfolio invested in the large-cap and mega-cap stocks.

  • MID-CAP
  • LARGE-CAP
  • SMALL-CAP
  • UNALLOCATED
  • MEGA-CAP
  • MICRO-CAP
Category%
MID-CAP32.7
LARGE-CAP27.5
SMALL-CAP15
UNALLOCATED12.5
MEGA-CAP9.2
MICRO-CAP2.7

Stocks belong to which Index?

About 66.5% of the stocks held by ARMISTICE CAPITAL, LLC either belong to S&P 500 or RUSSELL 2000 index.

  • RUSSELL 2000
  • Others
  • S&P 500
Index%
RUSSELL 200042.2
Others33.5
S&P 50024.3
Top 5 Winners (%)%
LCFY
locafy limited
284.6 %
TMCI
treace med concepts inc
197.0 %
FGI
fgi industries ltd
195.9 %
MU
micron technology inc
180.8 %
INTC
intel corp
170.5 %
Top 5 Winners ($)$
TVTX
travere therapeutics inc
87.7 M
IMVT
immunovant inc
36.3 M
UNH
unitedhealth group inc
24.0 M
HUM
humana inc
23.9 M
NBIX
neurocrine biosciences inc
23.2 M
Top 5 Losers (%)%
ONFO
onfolio holdings inc
-82.3 %
BEAT
heartbeam inc
-76.7 %
REED
reeds inc
-61.3 %
vsee health inc
-51.9 %
KTTA
pasithea therapeutics corp
-38.9 %
Top 5 Losers ($)$
SUPN
supernus pharmaceuticals
-11.8 M
HUBS
hubspot inc
-9.4 M
REGN
regeneron pharmaceuticals
-9.4 M
VSTM
verastem inc
-8.6 M
OFIX
orthofix med inc
-6.9 M

ARMISTICE CAPITAL, LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of ARMISTICE CAPITAL, LLC

ARMISTICE CAPITAL, LLC has 323 stocks in it's portfolio. About 12.1% of the portfolio is in top 10 stocks. SUPN proved to be the most loss making stock for the portfolio. TVTX was the most profitable stock for ARMISTICE CAPITAL, LLC last quarter.

$3.61BTotal Value
420Positions
14 Aug, 2026Last Reported
Current holdings of Current Stock Holdings of ARMISTICE CAPITAL, LLC, last reported on 14 Aug, 2026. Select a row with a linked ticker to view its historical trend.
ExpandHoldingsorted ascending% PortfolioShares Held$ Value% Change
AKTX
Akari Therapeutics Plc

Akari Therapeutics Plc

AKTX
ARMISTICE CAPITAL, LLC's holding in Akari Therapeutics Plc over time
0%0.00
$0.00
0%
decreased 100 percentsold off